TB Online is no longer maintained. This is an archive of the site. For news on TB please go to: https://globaltbcab.org/

Universal treatment of multidrug-resistant TB is possible within current budgets with generic production

Polly Clayden
Aug. 3, 2016, 1:03 p.m.

Generic production could make novel multidrug-resistant tuberculosis (MDR-TB) regimens available for US $53–507 per treatment course according to data presented at TB2016.

To read the full article, click here.


Source: HIV i-Base